AAM
CCXI

Arabesque Asset Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Arabesque Asset Management’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-8,359
Closed -$481K – 104
2020
Q2 		$481K Sell
8,359
-13,730
-62% -$747K 0.33% 68
2020
Q1 		$888K Buy
+22,089
New +$938K 1.84% 21

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Arabesque Asset Management's CCXI Position: Q3 2020 in Review

Arabesque Asset Management sold out of ChemoCentryx, Inc. (CCXI) in Q3 2020, closing a stake of 8,359 shares — an estimated $481K sold.

Arabesque Asset Management first reported a position in CCXI in Q1 2020 and held it in 2 quarters. The position peaked at $888K in Q1 2020. 204 funds tracked by Wall St. Rank hold CCXI as of Q3 2020.

  • Arabesque Asset Management reported no remaining ChemoCentryx, Inc. position as of Q3 2020 after selling out during the quarter.
  • Arabesque Asset Management sold 8,359 ChemoCentryx, Inc. shares in Q3 2020, an estimated $481K.
  • Arabesque Asset Management first reported a position in ChemoCentryx, Inc. in Q1 2020 and held it in 2 quarters.
  • Arabesque Asset Management's ChemoCentryx, Inc. position peaked at $888K in Q1 2020.
  • 204 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2020.

Based on Arabesque Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.